NORD Advocacy Agenda Includes End To Lifetime Caps, Reimbursement Of Some Off-Label Uses
This article was originally published in The Pink Sheet Daily
Executive Summary
Time is short for rare disease advocates to get their provisions included in federal health care reform legislation, group is warned.